Literature DB >> 24280059

Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells.

Christian M Girgis1, Roderick J Clifton-Bligh, Nancy Mokbel, Kim Cheng, Jenny E Gunton.   

Abstract

Vitamin D deficiency is linked to a range of muscle disorders including myalgia, muscle weakness, and falls. Humans with severe vitamin D deficiency and mice with transgenic vitamin D receptor (VDR) ablation have muscle fiber atrophy. However, molecular mechanisms by which vitamin D influences muscle function and fiber size remain unclear. A central question is whether VDR is expressed in skeletal muscle and is able to regulate transcription at this site. To address this, we examined key molecular and morphologic changes in C2C12 cells treated with 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)(2)D). As well as stimulating VDR expression, 25(OH)D and 1,25(OH)(2)D dose-dependently increased expression of the classic vitamin D target cytochrome P450, family 24, subfamily A, polypeptide 1 (CYP24A1), demonstrating the presence of an autoregulatory vitamin D-endocrine system in these cells. Luciferase reporter studies demonstrated that cytochrome P450, family 27, subfamily B, polypeptide 1 (CYP27B1) was functional in these cells. Both 25OHD and 1,25(OH)(2)D altered C2C12 proliferation and differentiation. These effects were related to the increased expression of genes involved in G(0)/G(1) arrest (retinoblastoma protein [Rb], 1.3-fold; ATM, 1.5-fold, both P < .05), downregulation of mRNAs involved in G(1)/S transition, including myc and cyclin-D1 (0.7- and 0.8-fold, both P < .05) and reduced phosphorylation of Rb protein (0.3-fold, P < .005). After serum depletion, 1,25(OH)(2)D (100nM) suppressed myotube formation with decreased mRNAs for key myogenic regulatory factors (myogenin, 0.5-fold; myf5, 0.4-fold, P < .005) but led to a 1.8-fold increase in cross-sectional size of individual myotubes associated with markedly decreased myostatin expression (0.2-fold, P < .005). These data show that vitamin D signaling alters gene expression in C2C12 cells, with effects on proliferation, differentiation, and myotube size.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24280059     DOI: 10.1210/en.2013-1205

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  62 in total

Review 1.  Steroid Hormone Vitamin D: Implications for Cardiovascular Disease.

Authors:  Linda L Demer; Jeffrey J Hsu; Yin Tintut
Journal:  Circ Res       Date:  2018-05-25       Impact factor: 17.367

2.  CXXC5 regulates differentiation of C2C12 myoblasts into myocytes.

Authors:  Guangming Li; Xiangli Ye; Xiyang Peng; Yun Deng; Wuzhou Yuan; Yongqing Li; Xiaoyang Mo; Xijun Wang; Yongqi Wan; Xianchu Liu; Tingfang Chen; Zhigang Jiang; Xiongwei Fan; Xiushan Wu; Yuequn Wang
Journal:  J Muscle Res Cell Motil       Date:  2014-11-30       Impact factor: 2.698

Review 3.  "Nutraceuticals" in relation to human skeletal muscle and exercise.

Authors:  Colleen S Deane; Daniel J Wilkinson; Bethan E Phillips; Kenneth Smith; Timothy Etheridge; Philip J Atherton
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-31       Impact factor: 4.310

Review 4.  Therapies for musculoskeletal disease: can we treat two birds with one stone?

Authors:  Christian M Girgis; Nancy Mokbel; Douglas J Digirolamo
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

Review 5.  Vitamin D: recent advances and implications for athletes.

Authors:  Joshua J Todd; L Kirsty Pourshahidi; Emeir M McSorley; Sharon M Madigan; Pamela J Magee
Journal:  Sports Med       Date:  2015-02       Impact factor: 11.136

Review 6.  The emerging biomolecular role of vitamin D in skeletal muscle.

Authors:  Rachele M Pojednic; Lisa Ceglia
Journal:  Exerc Sport Sci Rev       Date:  2014-04       Impact factor: 6.230

7.  Expression of the vitamin D receptor in skeletal muscle: are we there yet?

Authors:  J Wesley Pike
Journal:  Endocrinology       Date:  2014-09       Impact factor: 4.736

8.  Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims.

Authors:  Afsaneh Barzi; Dawn L Hershman; Cathee Till; William E Barlow; Scott Ramsey; Heinz-Josef Lenz; Howard S Hochster; Joseph M Unger
Journal:  Arch Osteoporos       Date:  2019-07-28       Impact factor: 2.617

Review 9.  Extraskeletal actions of vitamin D.

Authors:  Daniel D Bikle
Journal:  Ann N Y Acad Sci       Date:  2016-07       Impact factor: 5.691

Review 10.  More than healthy bones: a review of vitamin D in muscle health.

Authors:  S Bobo Tanner; Susan A Harwell
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.